ScholarLens Back to search
2024•Clinical Genitourinary CancerRequires access

Real-life Data on First- and Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer With Abiraterone, Enzalutamide and Cabazitaxel – A multicentric Study From Portugal

Francisco Botelho, Isaac Braga, Ricardo Leão, Frederico Teves, Jorge Dias, Filipe Rodrigues, Jorge Oliveira, I. Augusto, Catarina Portela, Joana Febra, Sandra Custódio, Patrícia Liu, Patrícia Gago, André Miranda, Carlos Silva, Luís Pacheco‐Figueiredo

Open publisher page 2 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Enzalutamide, Cabazitaxel, Medicine, Abiraterone, Prostate cancer, Oncology, Docetaxel, Abiraterone acetate

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Real-life Data on First- and Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer With Abiraterone, Enzalutamide and Cabazitaxel – A multicentric Study From Portugal — Research Paper | ScholarLens